or Try an Advanced Search...

    Technical Analysis for ONCY - Oncolytics Biotech Inc.

    Grade Last Price % Change Price Change
    F 0.98 -1.85% -0.02
    ONCY closed down 5.8 percent on Wednesday, November 20, 2024, on 52 percent of normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. It ran into resistance at its 50 day moving average.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ONCY trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish -1.85%
    Fell Below 200 DMA Bearish -1.85%
    180 Bearish Setup Bearish Swing Setup -1.85%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.85%
    Oversold Stochastic Weakness -1.85%
    Crossed Above 200 DMA Bullish -7.55%
    Stochastic Buy Signal Bullish -7.55%
    Oversold Stochastic Weakness -7.55%
    NR7 Range Contraction -1.51%
    Narrow Range Bar Range Contraction -1.51%
    Older End-of-Day Signals for ONCY ...

       Recent Intraday Alerts

    Alert Time
    Bearish 180 Entry about 1 hour ago
    Non-ADX 1,2,3,4 Bearish Retracement Entry about 1 hour ago
    Fell Below Previous Day's Low about 1 hour ago
    Down 1% about 1 hour ago
    Down 3% 1 day ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    ONCY Chart by TradingView
    Basic chart:

    Profile

    Oncolytics Biotech Inc is a development stage biopharmaceutical company. It is engaged in the discovery and development of pharmaceutical products for the treatment of cancer that have not been successfully treated with conventional therapeutics.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Treatment Of Cancer Pharmaceutical Products Oncolytics Biotech Synbio

    Is ONCY a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 Oncolytics Biotech Inc. (ONCY) Q3 2024 Earnings Call Transcript
    Nov 13 Oncolytics Biotech Inc (ONCY) Q3 2024 Earnings Call Highlights: Strategic Advances and ...
    Nov 12 Oncolytics Biotech GAAP EPS of -$0.12 misses by $0.04
    Nov 12 Oncolytics Biotech® Reports Third Quarter 2024 Financial Results and Operational Highlights
    Nov 12 Earnings Scheduled For November 12, 2024
    Oct 7 ONCY Stock Up on Regulatory Update From Breast Cancer Program
    Oct 7 Oncolytics targets accelerated approval for oncolytic virus therapy
    Oct 4 Oncolytics Biotech® Announces Key Progress and Upcoming Studies for Breast and Pancreatic Cancer Treatments, Prepares for FDA Accelerated Approval Path
    Sep 19 Oncolytics Biotech Reports "Favorable" Results for BRACELET-1 Breast Cancer Study
    Sep 19 Oncolytics Biotech® Reports Favorable Results for BRACELET-1 Breast Cancer Study Reinforcing Path to Funding of a Registration-Enabling Study
    See more ONCY news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.75
    52 Week Low 0.8401
    Average Volume 534,843
    200-Day Moving Average 1.06
    50-Day Moving Average 1.09
    20-Day Moving Average 1.11
    10-Day Moving Average 1.04
    Average True Range 0.08
    RSI (14) 40.83
    ADX 19.35
    +DI 19.30
    -DI 18.90
    Chandelier Exit (Long, 3 ATRs) 1.06
    Chandelier Exit (Short, 3 ATRs) 1.20
    Upper Bollinger Bands 1.28
    Lower Bollinger Band 0.95
    Percent B (%b) 0.15
    BandWidth 29.48
    MACD Line -0.04
    MACD Signal Line -0.02
    MACD Histogram -0.0173
    Fundamentals Value
    Market Cap 73.29 Million
    Num Shares 73.4 Million
    EPS -0.38
    Price-to-Earnings (P/E) Ratio -2.63
    Price-to-Sales 0.00
    Price-to-Book 3.58
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.15
    Resistance 3 (R3) 1.17 1.13 1.13
    Resistance 2 (R2) 1.13 1.09 1.12 1.12
    Resistance 1 (R1) 1.06 1.06 1.04 1.05 1.11
    Pivot Point 1.02 1.02 1.02 1.02 1.02
    Support 1 (S1) 0.96 0.99 0.94 0.95 0.89
    Support 2 (S2) 0.92 0.96 0.91 0.88
    Support 3 (S3) 0.86 0.92 0.87
    Support 4 (S4) 0.84